866-997-4948(US-Canada Toll Free)

United States Eye Drug Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the United States Eye Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Eye Drug in these regions, from 2012 to 2022 (forecast).

United States Eye Drug market competition by top manufacturers/players, with Eye Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Drops
Tablet & Capsule
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Eye Drug for each application, including
Glaucoma
Retinal Disease
Bacterial?Infection
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Eye Drug Market Report 2017
1 Eye Drug Overview
1.1 Product Overview and Scope of Eye Drug
1.2 Classification of Eye Drug by Product Category
1.2.1 United States Eye Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Eye Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Drops
1.2.4 Tablet & Capsule
1.3 United States Eye Drug Market by Application/End Users
1.3.1 United States Eye Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Glaucoma
1.3.3 Retinal Disease
1.3.4 Bacterial?Infection
1.3.5 Other
1.4 United States Eye Drug Market by Region
1.4.1 United States Eye Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Eye Drug Status and Prospect (2012-2022)
1.4.3 Southwest Eye Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Eye Drug Status and Prospect (2012-2022)
1.4.5 New England Eye Drug Status and Prospect (2012-2022)
1.4.6 The South Eye Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Eye Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Eye Drug (2012-2022)
1.5.1 United States Eye Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Eye Drug Revenue and Growth Rate (2012-2022)

2 United States Eye Drug Market Competition by Players/Suppliers
2.1 United States Eye Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Eye Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Eye Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Eye Drug Market Competitive Situation and Trends
2.4.1 United States Eye Drug Market Concentration Rate
2.4.2 United States Eye Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Eye Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Eye Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Eye Drug Sales and Market Share by Region (2012-2017)
3.2 United States Eye Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Eye Drug Price by Region (2012-2017)

4 United States Eye Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Eye Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Eye Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Eye Drug Price by Type (2012-2017)
4.4 United States Eye Drug Sales Growth Rate by Type (2012-2017)

5 United States Eye Drug Sales (Volume) by Application (2012-2017)
5.1 United States Eye Drug Sales and Market Share by Application (2012-2017)
5.2 United States Eye Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Eye Drug Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Eye Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Eye Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 bausch Lomb
6.3.2 Eye Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 bausch Lomb Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Laboratoire Riva
6.4.2 Eye Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Laboratoire Riva Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Jamp Pharma
6.5.2 Eye Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Jamp Pharma Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Fresenius
6.6.2 Eye Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Fresenius Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical?
6.7.2 Eye Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 SANDOZ
6.8.2 Eye Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 SANDOZ Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Greenstone
6.9.2 Eye Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Greenstone Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Mylan
6.10.2 Eye Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Mylan Eye Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GE Medical
6.12 Mint Pharmaceuticals
6.13 Laboratoires Thea
6.14 Taj Pharmaceuticals
6.15 Actavis
6.16 APOTEX
6.17 Sun Pharma

7 Eye Drug Manufacturing Cost Analysis
7.1 Eye Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Eye Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Eye Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Eye Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Eye Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Eye Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Eye Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Eye Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Eye Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Eye Drug
Figure United States Eye Drug Market Size (K Units) by Type (2012-2022)
Figure United States Eye Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Drops Product Picture
Figure Tablet & Capsule Product Picture
Figure United States Eye Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Eye Drug by Application in 2016
Figure Glaucoma Examples
Figure Retinal Disease Examples
Figure Bacterial?Infection Examples
Figure Other Examples
Figure United States Eye Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Eye Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Eye Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Eye Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Eye Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Eye Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Eye Drug Sales Share by Players/Suppliers
Figure 2017 United States Eye Drug Sales Share by Players/Suppliers
Figure United States Eye Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Eye Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Eye Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Eye Drug Revenue Share by Players/Suppliers
Figure 2017 United States Eye Drug Revenue Share by Players/Suppliers
Table United States Market Eye Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Eye Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Eye Drug Market Share of Top 3 Players/Suppliers
Figure United States Eye Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Eye Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Eye Drug Product Category
Table United States Eye Drug Sales (K Units) by Region (2012-2017)
Table United States Eye Drug Sales Share by Region (2012-2017)
Figure United States Eye Drug Sales Share by Region (2012-2017)
Figure United States Eye Drug Sales Market Share by Region in 2016
Table United States Eye Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Eye Drug Revenue Share by Region (2012-2017)
Figure United States Eye Drug Revenue Market Share by Region (2012-2017)
Figure United States Eye Drug Revenue Market Share by Region in 2016
Table United States Eye Drug Price (USD/Unit) by Region (2012-2017)
Table United States Eye Drug Sales (K Units) by Type (2012-2017)
Table United States Eye Drug Sales Share by Type (2012-2017)
Figure United States Eye Drug Sales Share by Type (2012-2017)
Figure United States Eye Drug Sales Market Share by Type in 2016
Table United States Eye Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Eye Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Eye Drug by Type (2012-2017)
Figure Revenue Market Share of Eye Drug by Type in 2016
Table United States Eye Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Eye Drug Sales Growth Rate by Type (2012-2017)
Table United States Eye Drug Sales (K Units) by Application (2012-2017)
Table United States Eye Drug Sales Market Share by Application (2012-2017)
Figure United States Eye Drug Sales Market Share by Application (2012-2017)
Figure United States Eye Drug Sales Market Share by Application in 2016
Table United States Eye Drug Sales Growth Rate by Application (2012-2017)
Figure United States Eye Drug Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Eye Drug Sales Growth Rate (2012-2017)
Figure Pfizer Eye Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Eye Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Eye Drug Sales Growth Rate (2012-2017)
Figure Novartis Eye Drug Sales Market Share in United States (2012-2017)
Figure Novartis Eye Drug Revenue Market Share in United States (2012-2017)
Table bausch Lomb Basic Information List
Table bausch Lomb Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure bausch Lomb Eye Drug Sales Growth Rate (2012-2017)
Figure bausch Lomb Eye Drug Sales Market Share in United States (2012-2017)
Figure bausch Lomb Eye Drug Revenue Market Share in United States (2012-2017)
Table Laboratoire Riva Basic Information List
Table Laboratoire Riva Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Laboratoire Riva Eye Drug Sales Growth Rate (2012-2017)
Figure Laboratoire Riva Eye Drug Sales Market Share in United States (2012-2017)
Figure Laboratoire Riva Eye Drug Revenue Market Share in United States (2012-2017)
Table Jamp Pharma Basic Information List
Table Jamp Pharma Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jamp Pharma Eye Drug Sales Growth Rate (2012-2017)
Figure Jamp Pharma Eye Drug Sales Market Share in United States (2012-2017)
Figure Jamp Pharma Eye Drug Revenue Market Share in United States (2012-2017)
Table Fresenius Basic Information List
Table Fresenius Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius Eye Drug Sales Growth Rate (2012-2017)
Figure Fresenius Eye Drug Sales Market Share in United States (2012-2017)
Figure Fresenius Eye Drug Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical? Basic Information List
Table Teva Pharmaceutical? Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical? Eye Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical? Eye Drug Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical? Eye Drug Revenue Market Share in United States (2012-2017)
Table SANDOZ Basic Information List
Table SANDOZ Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SANDOZ Eye Drug Sales Growth Rate (2012-2017)
Figure SANDOZ Eye Drug Sales Market Share in United States (2012-2017)
Figure SANDOZ Eye Drug Revenue Market Share in United States (2012-2017)
Table Greenstone Basic Information List
Table Greenstone Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Greenstone Eye Drug Sales Growth Rate (2012-2017)
Figure Greenstone Eye Drug Sales Market Share in United States (2012-2017)
Figure Greenstone Eye Drug Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Eye Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Eye Drug Sales Growth Rate (2012-2017)
Figure Mylan Eye Drug Sales Market Share in United States (2012-2017)
Figure Mylan Eye Drug Revenue Market Share in United States (2012-2017)
Table GE Medical Basic Information List
Table Mint Pharmaceuticals Basic Information List
Table Laboratoires Thea Basic Information List
Table Taj Pharmaceuticals Basic Information List
Table Actavis Basic Information List
Table APOTEX Basic Information List
Table Sun Pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Eye Drug
Figure Manufacturing Process Analysis of Eye Drug
Figure Eye Drug Industrial Chain Analysis
Table Raw Materials Sources of Eye Drug Major Players/Suppliers in 2016
Table Major Buyers of Eye Drug
Table Distributors/Traders List
Figure United States Eye Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Eye Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Eye Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Eye Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Eye Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Eye Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Eye Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Eye Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Eye Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Eye Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Eye Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Eye Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Eye Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *